NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
Back to search
Official data from USPTO
CEBIOTEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 7, 42
Filing date
09/29/2022
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
ES
Examiner
WATKINS, JONATHAN RALPH
Law office
O40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized text "CEBIOTEX" in teal, to the left of a circular design in light blue, which is fragmented into many polygons formed by intersecting transparent straight lines. Two of the polygons therein are depicted in teal, while the rest are depicted in light blue.
Holders and representatives
Holders
CEBIOTEX, S.L.
Representatives
Justin R. Young DTL Ltd.
Technical classification
Nice Classes
Class 5Class 7Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents for administering pharmaceuticals in the form of films which facilitate administration of pharmaceutical products; biopharmaceuticals for cancer treatment; drug delivery compounds that facilitate the delivery of pharmaceuticals; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating cancer; pharmaceutical preparations for oncological use; pharmaceutical preparations and substances for use in oncology; Veterinary products and substances for facilitating the delivery of pharmaceutical preparations; where all aforementioned goods exclude eye drops and pomades for ophthalmic or otorhinolaryngology use
Class 7
3D printers; 3D bioprinters; three-dimensional (3D) living tissue manufacturing machines in the nature of 3D printers; machines for manufacturing medical and veterinary drugsimplantspreparations
Class 42
Bacteriological research and consultancy; consultancy relating to research and development in the field of therapeutic drugs; development of pharmaceutical preparations and medicines; development of pharmaceutical products; design of diagnostic apparatus and equipment; biotechnological research; scientific research for medical purposes in oncology; scientific research relating to chemistry; research regarding pharmaceutical products; medical research; stem cell research; biochemical research and analysis; research and development of products; conducting clinical trials for pharmaceutical products for others; scientific laboratory services; information and data systems design in the field of medical and veterinary research and development; pharmaceutical and medical research services; biomedical research services; research and development services in bacteriology; provision of medical and scientific research information regarding results of clinical trials relating to pharmaceutical products; informationadvisory and consultancy services in relation to the aforesaid services
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/09/2024
FIMP
FINAL DISPOSITION PROCESSED
12/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/07/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/17/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/17/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/15/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/18/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/18/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/18/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/18/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/18/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/18/2024
RFNT
REFUSAL PROCESSED BY IB
09/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/17/2023
RFRR
REFUSAL PROCESSED BY MPU
08/17/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/19/2023
CNRT
NON-FINAL ACTION WRITTEN
07/18/2023
DOCK
ASSIGNED TO EXAMINER
07/14/2023
MAFR
APPLICATION FILING RECEIPT MAILED
11/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/18/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/17/2022
Continuous trademark protection
Get notified about every new filing that threatens CEBIOTEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.